Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2001 7
2002 4
2003 3
2004 8
2005 3
2006 5
2007 5
2008 3
2009 10
2010 13
2011 7
2012 8
2013 11
2014 3
2015 9
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

97 results
Results by year
Filters applied: . Clear all
Page 1
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein PM, Ingle JN, Wolmark N. Romond EH, et al. N Engl J Med. 2005 Oct 20;353(16):1673-84. doi: 10.1056/NEJMoa052122. N Engl J Med. 2005. PMID: 16236738 Free article. Clinical Trial.
Ductal carcinoma in situ: an overview.
Duggal S, Robin J, Julian TB. Duggal S, et al. Expert Rev Anticancer Ther. 2013 Aug;13(8):955-62. doi: 10.1586/14737140.2013.820557. Expert Rev Anticancer Ther. 2013. PMID: 23984897 Review.
Ductal carcinoma in situ: a rose by any other name.
Wickerham DL, Julian TB. Wickerham DL, et al. J Natl Cancer Inst. 2013 Oct 16;105(20):1521-2. doi: 10.1093/jnci/djt268. Epub 2013 Sep 25. J Natl Cancer Inst. 2013. PMID: 24068770 Free PMC article. No abstract available.
97 results